Torthaí Cuardaigh d'Údair

1

Á lódáil...

COMMENTS ON NEW EUROPEAN GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION

le D. V. Nebieridze
Foilsithe 2016-01-01

Faigh an téacs iomlán

Artigo

2

Á lódáil...

COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»

le D. V. Nebieridze
Foilsithe 2015-12-01

Faigh an téacs iomlán

Artigo

3

Á lódáil...

CALCIUM ANTAGONISTS IN CLINICAL PRACTICE: FOCUS ON METABOLIC AND VASCULAR EFFECTS

le D. V. Nebieridze
Foilsithe 2015-12-01

Faigh an téacs iomlán

Artigo

4

Á lódáil...

Hyperuricemia a New Cardiovascular Risk Factor

le D. V. Nebieridze
Foilsithe 2020-03-01

Faigh an téacs iomlán

Artigo

5

Á lódáil...

Topical issues of beta-blockers use in various clinical situations

le D. V. Nebieridze
Foilsithe 2018-07-01

Faigh an téacs iomlán

Artigo

6

Á lódáil...

SYSTOLIC ARTERIAL HYPERTENSION: THE PLACE OF ANGIOTENSIN II RECEPTOR BLOCKERS

le D. V. Nebieridze
Foilsithe 2002-02-01

Faigh an téacs iomlán

Artigo

7

Á lódáil...

COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»

le D. V. Nebieridze
Foilsithe 2015-12-01

Faigh an téacs iomlán

Artigo

8

Á lódáil...

Topical questions of beta-blockers application in clinical practice

le D V Nebieridze
Foilsithe 2014-12-01

Faigh an téacs iomlán

Artigo

9

Á lódáil...

ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM?

le D. V. Nebieridze, A. S. Safarian
Foilsithe 2016-01-01

Faigh an téacs iomlán

Artigo

10

Á lódáil...

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?

le D. V. Nebieridze, T. V. Kamyshova
Foilsithe 2015-12-01

Faigh an téacs iomlán

Artigo

11

Á lódáil...

Sympathetic hyperactivity in patients with hypertension: pathogenesis and treatment. Part II

le A. S. Safaryan, D. V. Nebieridze
Foilsithe 2021-10-01

Faigh an téacs iomlán

Artigo

12

Á lódáil...

New potential of ACE inhibitors in clinical practice

le D. V. Nebieridze, A. S. Safaryan
Foilsithe 2010-10-01

Faigh an téacs iomlán

Artigo

13

Á lódáil...

High-risk patients: modern treatment strategy

le D. V. Nebieridze, A. Meliya
Foilsithe 2010-12-01

Faigh an téacs iomlán

Artigo

14

Á lódáil...

Place of imidazoline receptor agonists in the treatment of hypertension

le D. V. Nebieridze, A. S. Safaryan
Foilsithe 2022-01-01

Faigh an téacs iomlán

Artigo

15

Á lódáil...

Imidazoline receptor agonists: more than blood pressure reduction?

le D. V. Nebieridze, S. V. Nedogoda
Foilsithe 2006-04-01

Faigh an téacs iomlán

Artigo

16

Á lódáil...

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?

le D. V. Nebieridze, T. V. Kamyshova
Foilsithe 2015-12-01

Faigh an téacs iomlán

Artigo

17

Á lódáil...

PREVALENCE OF HYPERURICEMIA AMONG PATIENTS WITH METABOLIC SYNDROME: RESULTS OF THE STUDY IN REAL CLINICAL PRACTICE

le D. V. Nebieridze, N. V. Dolgushina
Foilsithe 2017-12-01

Faigh an téacs iomlán

Artigo

18

Á lódáil...

The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 2)

le A. S. Safaryan, V. S. Sargsyan, D. V. Nebieridze
Foilsithe 2020-07-01

Faigh an téacs iomlán

Artigo

19

Á lódáil...

IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS?

le A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova
Foilsithe 2017-11-01

Faigh an téacs iomlán

Artigo

20

Á lódáil...

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues

le N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan
Foilsithe 2019-01-01

Faigh an téacs iomlán

Artigo

Cuardach Cúng